Physician profile
Lisa A Schnick
NPI 1215921853
$1,834.55
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,521 · 2020: $313.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $316.38 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $168.93 | 2019 | |
| Amarin Pharma, INC. | $164.75 | 2019-2020 | |
| Pfizer INC. | $164.45 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $148.65 | 2019-2020 | |
| Novo Nordisk INC | $147.88 | 2019-2020 | |
| Lilly USA, LLC | $139.12 | 2019 | |
| Abbvie INC. | $122.95 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.63 | 2019-2020 | |
| Antares Pharma, INC. | $59.17 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $45.85 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $44.25 | 2019 | |
| Shire North American Group INC | $36.42 | 2019 | |
| Eisai INC. | $28.58 | 2019 | |
| Janssen Pharmaceuticals, INC | $27.28 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $22.65 | 2019 | |
| Collegium Pharmaceutical, INC. | $19.64 | 2019 | |
| Hologic Sales and Service, LLC | $15.99 | 2020 | |
| Ironshore Pharmaceuticals INC. | $15.03 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.66 | 2019 | |
| Allergan, INC. | $12.60 | 2019 | |
| Alfasigma USA, INC. | $11.69 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Schnick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.